MCID: NDL009
MIFTS: 42

Nodular Basal Cell Carcinoma

Categories: Cancer diseases, Skin diseases

Aliases & Classifications for Nodular Basal Cell Carcinoma

MalaCards integrated aliases for Nodular Basal Cell Carcinoma:

Name: Nodular Basal Cell Carcinoma 12 15
Skin Nodulo-Ulcerative Basal Cell Carcinoma 12
Circumscribed Solid Basal Cell Carcinoma 12
Skin Nodular Solid Basal Cell Carcinoma 72
Nodulo-Ulcerative Basal Cell Carcinoma 72
Skin Solid Basal Cell Carcinoma 12
Skin Nodular Basal Cell Carcinoma 72
Basal Cell Carcinoma, Nodular 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4280
NCIt 50 C62282
UMLS 72 C0862887 C1304300 C1879347

Summaries for Nodular Basal Cell Carcinoma

Disease Ontology : 12 A basal cell carcinoma characterized by elevated, pearl shaped nodules with telengactisae on the surface and periphery.

MalaCards based summary : Nodular Basal Cell Carcinoma, also known as skin nodulo-ulcerative basal cell carcinoma, is related to basal cell carcinoma and skin carcinoma. An important gene associated with Nodular Basal Cell Carcinoma is WNT16 (Wnt Family Member 16), and among its related pathways/superpathways are Pathways in cancer and Presynaptic function of Kainate receptors. The drugs Imiquimod and Adjuvants, Immunologic have been mentioned in the context of this disorder. Affiliated tissues include skin, lymph node and breast.

Related Diseases for Nodular Basal Cell Carcinoma

Graphical network of the top 20 diseases related to Nodular Basal Cell Carcinoma:



Diseases related to Nodular Basal Cell Carcinoma

Symptoms & Phenotypes for Nodular Basal Cell Carcinoma

Drugs & Therapeutics for Nodular Basal Cell Carcinoma

Drugs for Nodular Basal Cell Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 24)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Imiquimod Approved, Investigational Phase 4 99011-02-6 57469
2 Adjuvants, Immunologic Phase 4
3 Immunologic Factors Phase 4
4 Interferon Inducers Phase 4
5 interferons Phase 4
6
Aminolevulinic acid Approved Phase 3 106-60-5 137
7 Methyl 5-aminolevulinate Phase 3
8 Dermatologic Agents Phase 3
9 Photosensitizing Agents Phase 3
10 Anesthetics Phase 3
11
Fluorouracil Approved Phase 1, Phase 2 51-21-8 3385
12
Cisplatin Approved Phase 1, Phase 2 15663-27-1 84093 441203 2767
13 Interferon-gamma Phase 1, Phase 2
14 Pharmaceutical Solutions Phase 1, Phase 2
15
Doxorubicin Approved, Investigational Phase 1 23214-92-8 31703
16
Liposomal doxorubicin Phase 1 31703
17 Anti-Bacterial Agents Phase 1
18 Topoisomerase Inhibitors Phase 1
19 Antibiotics, Antitubercular Phase 1
20
Lidocaine Approved, Vet_approved 137-58-6 3676
21
Racepinephrine Approved 329-65-7 838
22
Epinephrine Approved, Vet_approved 51-43-4 5816
23 Immunosuppressive Agents
24 Epinephryl borate

Interventional clinical trials:

(show all 19)
# Name Status NCT ID Phase Drugs
1 Topical Imiquimod 5% Cream in the Treatment of Nodular Basal Cell Carcinoma After Initial Treatment With Curettage Completed NCT00314756 Phase 4 imiquimod
2 A Randomized Open Label Study to Evaluate the Safety and Efficacy if Imiquimod 5% Cream Applied 3 Times Per Week for 8 or 12 Weeks in the Treatment of Low Risk Nodular Basal Cell Carcinoma Completed NCT00204555 Phase 4 Imiquimod
3 A Multicenter, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix 160 mg/g Cream in Comparison to PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma Completed NCT00472108 Phase 3
4 A Multicentre, Phase III, Double Blind Study of Photodynamic Therapy (PDT) With Metvix® 160 mg/g Cream in Comparison to PDT With Placebo Cream in Patients With Primary Nodular Basal Cell Carcinoma. Completed NCT00472043 Phase 3
5 Surgical Excision Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma: an Open, Non-inferiority, Randomized Controlled Trial Active, not recruiting NCT02242929 Phase 3 Imiquimod 5% cream with prior curettage
6 Investigation of the Effectiveness of Non-Coherent Blue Light in Intralesional Photodynamic of Basal Cell Carcinoma Unknown status NCT00747903 Phase 2 aminolevulinic acid hydrochloride
7 A Multi-center, Randomized, Double-blind, Parallel-group, Vehicle-controlled Study to Determine the Safety of PEP005 0.0025%, 0.01% and 0.05% Gel With Two Treatment Schedules, Day 1 & 2 or Day 1 & 8 Applications to Nodular Basal Cell Carcinoma Completed NCT00108121 Phase 2 PEP005
8 A Phase 1/2a Study of the Efficacy and Safety of ASN-002 Alone or in Combination With 5-FU in Adult Patients With Low-risk Nodular Basal Cell Carcinoma Completed NCT02550678 Phase 1, Phase 2 5-FU
9 Investigation of Local Skin Reactions and Safety After Combined Treatment of Basal Cell Carcinoma Using Ablative Fractional Laser and Ingenol Mebutate - an Exploratory, Prospective, Open-label Phase 2a Trial. Completed NCT03569345 Phase 1, Phase 2 AFXl-assisted ingenol mebutate delivery
10 Tolerability of Laser-assisted Cisplatin + 5-fluorouracil― an Exploratory Proof of Concept Study of Topical Combination Chemotherapy for Basal Cell Carcinoma Recruiting NCT03541252 Phase 1, Phase 2 AFL-assisted cisplatin+5-FU
11 Bi-center, Open Label, Non-comparative Trial Exploring Efficacy and Safety of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma (nBCC) Terminated NCT01808950 Phase 1, Phase 2 0.06% Resiquimod Gel - A;0.06% Resiquimod Gel - B;0.06% Resiquimod Gel - C
12 Er:YAG Ablative Fractional Laser Assisted-Photodynamic Therapy Versus Photodynamic Therapy for Nodular Basal Cell Carcinoma in Asian: A Prospective, Randomized Study With 12 Months Follow-up Completed NCT02018679 Phase 1
13 An Open-Label Dose Escalation Trial to Evaluate Dose Limiting Toxicity (DLT), Maximum Tolerated Dose (MTD), Safety, and Tolerability of Microneedle Arrays Containing Doxorubicin (D-MNA) in Participants With Basal Cell Carcinoma (BCC) Not yet recruiting NCT03646188 Phase 1 Placebo-containing MNA;25 µg doxorubicin-containing MNA;50 µg doxorubicin-containing MNA;100 µg doxorubicin-containing MNA;200 µg doxorubicin-containing MNA
14 Melanocyte Features and Its Influence in Pigmentation in Basal Cell Carcinoma in the Mexican Population Unknown status NCT02576769
15 A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma Completed NCT00571363
16 A Randomized Controlled Blinded Multi-centre Study of Photodynamic Therapy With Methyl-aminolevulinate Comparing a Simplified Regime With the Approved Regime in Patients With Clinical Low-risk Superficial and Nodular Basal Cell Carcinoma. Completed NCT01482104 MAL-PDT re-treatment;usual MAL-PDT
17 Randomized Pilot Study of Treatment for Basal Cell Carcinoma Using the Multiplex 595/1064 nm Laser Completed NCT02270645
18 Sentinel Lymph Node Biopsy in Porocarcinoma: A Case Reports Completed NCT03647631
19 Clinical Diagnosis Versus Histological Diagnosis by Punch Biopsy to Determine the Subtype of Basal Cell Carcinoma Completed NCT01370824

Search NIH Clinical Center for Nodular Basal Cell Carcinoma

Genetic Tests for Nodular Basal Cell Carcinoma

Anatomical Context for Nodular Basal Cell Carcinoma

MalaCards organs/tissues related to Nodular Basal Cell Carcinoma:

41
Skin, Lymph Node, Breast

Publications for Nodular Basal Cell Carcinoma

Articles related to Nodular Basal Cell Carcinoma:

(show top 50) (show all 186)
# Title Authors PMID Year
1
[Young male patient with unusual space-occupying lesion of the lower eyelid]. 38
31359135 2019
2
Utilization of optical coherence tomography as a noninvasive, bedside imaging technique to identify residual nodular basal cell carcinoma at a well-healed and clinically unidentifiable biopsy site. 38
30771419 2019
3
Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature. 38
31361351 2019
4
Excision of nodular basal cell carcinoma involving the lower eyelid tarsal skin using a grey line-splitting, posterior lamella-sparing technique. 38
29461902 2019
5
Photodynamic therapy: A targeted literature review focussing on outcomes and optimisation in solid organ transplant recipients. 38
31012102 2019
6
Skin cancer incidence in rural workers at a reference hospital in western Paraná. 38
31090820 2019
7
Basal Cell Carcinoma Associated with Secondary Localized Cutaneous Amyloid Deposits: Case Report and Review. 38
30899630 2019
8
Dermoscopy Patterns and Histopathological Findings in Nodular Basal Cell Carcinoma-Study on 68 Cases. 38
31297272 2019
9
Ultrasonographic features of superficial and nodular basal cell carcinoma. 38
30534655 2018
10
A systematic review on the use of cryotherapy versus other treatments for basal cell carcinoma. 38
30695972 2018
11
Intradermal Delivery of a Near-Infrared Photosensitizer Using Dissolving Microneedle Arrays. 38
29864428 2018
12
Solitary plantar basal cell carcinoma. 38
29924227 2018
13
Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel. 38
29785331 2018
14
Analysis of hedgehog signaling in periocular sebaceous carcinoma. 38
29423837 2018
15
Eyelid Reconstruction: Pediculated versus Non-Pediculated. 38
29351708 2018
16
An Experimental and Numerical Study on Nodular Gel Phantom during Cryotherapy. 38
29734423 2018
17
Programmed Death-1 Pathway in Orbital Invasion of Cutaneous Carcinomas. 38
28350690 2018
18
Assessment of singlet oxygen dosimetry concepts in photodynamic therapy through computational modeling. 38
29292205 2018
19
Macrophage subtypes in recurrent nodular basal cell carcinoma after Mohs micrographic surgery. 38
28994114 2017
20
Superiorly based nasolabial island flap for reconstruction of the lateral lower eyelid 38
29306222 2017
21
Dynamic thiol/disulphide homeostasis in patients with basal cell carcinoma. 38
28067074 2017
22
Injectable Diphenhydramine Used as Anaesthetic for Wide Local Excision With Flap Closure. 38
27920067 2017
23
Basal Cell Carcinoma Arising in a Breast Augmentation Scar. 38
28130559 2017
24
Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. 38
27932240 2017
25
A rare dermoscopic pattern of nodular basal cell carcinoma with amyloid deposition. 38
28087032 2017
26
Auricular Hemosiderosis in a Diabetic Patient. 38
28859747 2017
27
Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area. 38
28300740 2017
28
A Multicenter Clinical Study of Expected and Unexpected Side Reactions During and After Skin Cancer Treatment by Photodynamic Therapy. 38
28528604 2017
29
Photodynamic therapy versus surgical excision to basal cell carcinoma: meta-analysis. 38
27363535 2016
30
A retrospective study on the effectiveness of curettage and electrodesiccation for clinically suspected primary nodular basal cell carcinoma. 38
27229620 2016
31
An Interesting Case of Basal Cell Carcinoma with Raynaud's Phenomenon Following Chronic Arsenic Exposure. 38
28029677 2016
32
Altered Expression of PRKX, WNT3 and WNT16 in Human Nodular Basal Cell Carcinoma. 38
27630294 2016
33
[Development of a PCR for the detection and quantification of parasitism by Demodex folliculorum infestation in biopsies of skin neoplasms periocular area]. 38
27305511 2016
34
The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial. 38
27067393 2016
35
Fibroepithelioma of Pinkus in continuity with nodular basal cell carcinoma: A rare presentation. 38
27559504 2016
36
Fibroepithelioma of Pinkus in continuity with a pigmented nodular basal cell carcinoma (BCC): A dermoscopic and histologic correlation. 38
27085246 2016
37
Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial. 38
26551044 2016
38
Daylight photodynamic therapy with methyl aminolaevulinate in patients with actinic keratoses: a preliminary experience in Southern Italy. 38
25279493 2016
39
Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers. 38
26841041 2016
40
Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses. 38
26985197 2016
41
Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response. 38
26538104 2015
42
Dermoscopic Findings in Trichoblastoma. 38
26032870 2015
43
A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma. 38
25913533 2015
44
European Dermatology Forum Guidelines on topical photodynamic therapy. 38
26065545 2015
45
Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma. 38
26207112 2015
46
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. 38
25885553 2015
47
Dermoscopy margin delineation in radiotherapy planning for superficial or nodular basal cell carcinoma. 38
25204461 2015
48
Differentiating Early Stage Cystic Keratoacanthoma, Nodular Basal Cell Carcinoma, and Excoriated Acne Vulgaris by Clinical Exam, Dermoscopy, and Optical Coherence Tomography: A Report of 3 Cases. 38
26060518 2015
49
Prospective differentiation of clinically difficult to distinguish nodular basal cell carcinomas and intradermal nevi by non-invasive Reflectance Confocal Microscopy: a case series study. 38
24841762 2015
50
Modified Tripier flap in reconstruction of the lower eyelid. 38
25672307 2015

Variations for Nodular Basal Cell Carcinoma

Cosmic variations for Nodular Basal Cell Carcinoma:

9 (show top 50) (show all 687)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM6926860 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.5825G>A p.G1942E 16:72796857-72796857 12
2 COSM6969201 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.11050G>A p.D3684N 16:72787226-72787226 12
3 COSM6953811 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.1991C>T p.S664F 16:72958155-72958155 12
4 COSM6926862 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.1261G>A p.G421R 16:72958885-72958885 12
5 COSM6936924 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.10847C>T p.S3616F 16:72787429-72787429 12
6 COSM3691166 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.2084C>T p.P695L 16:72958062-72958062 12
7 COSM6926861 ZFHX3 skin,NS,carcinoma,basal cell carcinoma c.1655C>T p.S552F 16:72958491-72958491 12
8 COSM212945 XPO1 skin,NS,carcinoma,basal cell carcinoma c.782G>A p.R261Q 2:61496985-61496985 12
9 COSM6936922 TSC2 skin,NS,carcinoma,basal cell carcinoma c.2060C>T p.S687F 16:2071897-2071897 12
10 COSM6926855 TSC2 skin,NS,carcinoma,basal cell carcinoma c.679T>A p.C227S 16:2056674-2056674 12
11 COSM6953809 TSC2 skin,NS,carcinoma,basal cell carcinoma c.869C>T p.P290L 16:2058767-2058767 12
12 COSM6912933 TRAF7 skin,NS,carcinoma,basal cell carcinoma c.1802C>T p.T601I 16:2176104-2176104 12
13 COSM6949578 TP63 skin,NS,carcinoma,basal cell carcinoma c.1922C>T p.A641V 3:189894381-189894381 12
14 COSM44071 TP53 skin,NS,carcinoma,basal cell carcinoma c.955A>G p.K319E 17:7673573-7673573 12
15 COSM44097 TP53 skin,NS,carcinoma,basal cell carcinoma c.530C>T p.P177L 17:7675082-7675082 12
16 COSM10812 TP53 skin,NS,carcinoma,basal cell carcinoma c.722C>T p.S241F 17:7674241-7674241 12
17 COSM10988 TP53 skin,NS,carcinoma,basal cell carcinoma c.772G>A p.E258K 17:7674191-7674191 12
18 COSM45074 TP53 skin,NS,carcinoma,basal cell carcinoma c.829T>G p.C277G 17:7673791-7673791 12
19 COSM10728 TP53 skin,NS,carcinoma,basal cell carcinoma c.839G>A p.R280K 17:7673781-7673781 12
20 COSM45739 TP53 skin,NS,carcinoma,basal cell carcinoma c.677G>C p.G226A 17:7674286-7674286 12
21 COSM44295 TP53 skin,NS,carcinoma,basal cell carcinoma c.993+1G>A p.? 17:7673534-7673534 12
22 COSM10939 TP53 skin,NS,carcinoma,basal cell carcinoma c.832C>T p.P278S 17:7673788-7673788 12
23 COSM10650 TP53 skin,NS,carcinoma,basal cell carcinoma c.529C>T p.P177S 17:7675083-7675083 12
24 COSM10662 TP53 skin,NS,carcinoma,basal cell carcinoma c.743G>A p.R248Q 17:7674220-7674220 12
25 COSM43665 TP53 skin,NS,carcinoma,basal cell carcinoma c.746G>C p.R249T 17:7674217-7674217 12
26 COSM45774 TP53 skin,NS,carcinoma,basal cell carcinoma c.899C>G p.P300R 17:7673721-7673721 12
27 COSM10749 TP53 skin,NS,carcinoma,basal cell carcinoma c.830G>T p.C277F 17:7673790-7673790 12
28 COSM10660 TP53 skin,NS,carcinoma,basal cell carcinoma c.818G>A p.R273H 17:7673802-7673802 12
29 COSM11449 TP53 skin,NS,carcinoma,basal cell carcinoma c.388C>T p.L130F 17:7675224-7675224 12
30 COSM10771 TP53 skin,NS,carcinoma,basal cell carcinoma c.749C>T p.P250L 17:7674214-7674214 12
31 COSM44068 TP53 skin,NS,carcinoma,basal cell carcinoma c.532C>A p.H178N 17:7675080-7675080 12
32 COSM11152 TP53 skin,NS,carcinoma,basal cell carcinoma c.700T>C p.Y234H 17:7674263-7674263 12
33 COSM10768 TP53 skin,NS,carcinoma,basal cell carcinoma c.535C>T p.H179Y 17:7675077-7675077 12
34 COSM45834 TP53 skin,NS,carcinoma,basal cell carcinoma c.409C>A p.L137M 17:7675203-7675203 12
35 COSM10654 TP53 skin,NS,carcinoma,basal cell carcinoma c.637C>T p.R213* 17:7674894-7674894 12
36 COSM10905 TP53 skin,NS,carcinoma,basal cell carcinoma c.451C>T p.P151S 17:7675161-7675161 12
37 COSM6932 TP53 skin,NS,carcinoma,basal cell carcinoma c.733G>A p.G245S 17:7674230-7674230 12
38 COSM10648 TP53 skin,NS,carcinoma,basal cell carcinoma c.524G>A p.R175H 17:7675088-7675088 12
39 COSM45424 TP53 skin,NS,carcinoma,basal cell carcinoma c.781A>T p.S261C 17:7674182-7674182 12
40 COSM10656 TP53 skin,NS,carcinoma,basal cell carcinoma c.742C>T p.R248W 17:7674221-7674221 12
41 COSM10659 TP53 skin,NS,carcinoma,basal cell carcinoma c.817C>T p.R273C 17:7673803-7673803 12
42 COSM10794 TP53 skin,NS,carcinoma,basal cell carcinoma c.796G>A p.G266R 17:7673824-7673824 12
43 COSM43582 TP53 skin,NS,carcinoma,basal cell carcinoma c.454C>T p.P152S 17:7675158-7675158 12
44 COSM10704 TP53 skin,NS,carcinoma,basal cell carcinoma c.844C>T p.R282W 17:7673776-7673776 12
45 COSM6549 TP53 skin,NS,carcinoma,basal cell carcinoma c.743G>T p.R248L 17:7674220-7674220 12
46 COSM10726 TP53 skin,NS,carcinoma,basal cell carcinoma c.856G>A p.E286K 17:7673764-7673764 12
47 COSM45304 TP53 skin,NS,carcinoma,basal cell carcinoma c.375+1G>A p.? 17:7675993-7675993 12
48 COSM10867 TP53 skin,NS,carcinoma,basal cell carcinoma c.797G>A p.G266E 17:7673823-7673823 12
49 COSM43714 TP53 skin,NS,carcinoma,basal cell carcinoma c.836G>A p.G279E 17:7673784-7673784 12
50 COSM44226 TP53 skin,NS,carcinoma,basal cell carcinoma c.380C>T p.S127F 17:7675232-7675232 12

Expression for Nodular Basal Cell Carcinoma

Search GEO for disease gene expression data for Nodular Basal Cell Carcinoma.

Pathways for Nodular Basal Cell Carcinoma

GO Terms for Nodular Basal Cell Carcinoma

Cellular components related to Nodular Basal Cell Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endocytic vesicle membrane GO:0030666 8.96 WNT3 PTCH1
2 intermediate filament GO:0005882 8.8 KRT31 KRT15 BFSP1

Biological processes related to Nodular Basal Cell Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytoskeleton organization GO:0007010 9.33 KRT31 KRT15 BFSP1
2 cornification GO:0070268 9.32 KRT31 KRT15
3 cell fate commitment GO:0045165 9.26 WNT3 WNT16
4 keratinocyte proliferation GO:0043616 8.96 WNT16 PTCH1
5 epidermis development GO:0008544 8.8 PTCH1 KRT31 KRT15

Molecular functions related to Nodular Basal Cell Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 frizzled binding GO:0005109 8.96 WNT3 WNT16
2 structural constituent of cytoskeleton GO:0005200 8.8 KRT31 KRT15 BFSP1

Sources for Nodular Basal Cell Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....